Immediate Impact
66 standout
Citing Papers
KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS
2024 Standout
Chemically Modified Platforms for Better RNA Therapeutics
2024 Standout
Works of Mini Michael being referenced
ILLUMINATE-B, a Phase 3 Open-Label Study to Evaluate Lumasiran, an RNAi Therapeutic, in Young Children with Primary Hyperoxaluria Type 1 (PH1)
2020
Interventions for Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura: A Systematic Review of Randomized Controlled Trials
2008
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Mini Michael | 146 | 135 | 218 | 167 | 32 | 569 | |
| Anna V. Murphy | 110 | 153 | 133 | 94 | 31 | 623 | |
| Sean O’Regan | 89 | 124 | 126 | 74 | 27 | 642 | |
| J. S. Cameron | 130 | 78 | 280 | 110 | 34 | 580 | |
| Maria Roszkowska–Blaim | 88 | 111 | 266 | 44 | 77 | 490 | |
| Gérard Champion | 93 | 261 | 50 | 110 | 17 | 518 | |
| G. H. Neild | 192 | 51 | 215 | 122 | 34 | 580 | |
| Pornsak Dissaneewate | 54 | 102 | 218 | 41 | 33 | 507 | |
| Sylvie Nathanson | 41 | 102 | 170 | 219 | 32 | 513 | |
| C.P. Rance | 112 | 67 | 172 | 42 | 23 | 583 | |
| Elisa Ylinen | 160 | 237 | 218 | 31 | 29 | 553 |
All Works
Login with ORCID to disown or claim papers
Loading papers...